Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF678 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | CAMP | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | WDR44 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | PPM1L | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | YME1L1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | HEATR5B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | LRRC15 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | OR2B11 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
mRNA | LATS2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
mRNA | BMP4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |